Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 2002;113:42–55.

Recognizing the real threat of biological terror.

Richard P Wenzel 1
PMCID: PMC2194471  PMID: 12053717

Abstract

Weapons of mass destruction can be used to harm and terrorize populations. Such weapons include those with chemical, nuclear or biological properties. Obviously computer viruses can add additional barriers to a quick response. The most effective, least costly and greatest threats are biologicals. Biological terror is not new, and biological weapons have been used for centuries. However, as a result of modern technology, the risks are greater now and the outcomes more terrible. Today they include live pathogens, various toxins, and theoretically "bioregulators"--biochemicals affecting cell signaling. Altered cell signaling could be used to induce apoptosis-cell death, or a heightened outpouring of cytokines mimicking overwhelming sepsis, or even an intracellular, biochemical "strike" causing cellular paralysis. Biological weaponeers now have the frightening ability to alter the genetic makeup of pathogens, rendering them resistant not only to available antibiotic therapy but also to currently effective vaccines. In dark corners of some fringe groups, bioweaponeers are searching for the capability of designing pathogens that target specific races, by virtue of discriminating ligands (1). The resulting morbidity and mortality from use of any biological weapons will be accompanied by chaos, governmental and social instability, panic, an extraordinary utilization of available resources, and an ongoing epidemic of sleepless nights (2,3). Herein I will review some of the issues and some of the currently available biological weapons. The major goal is to highlight the clinical presentations of patients with infections that could be used as biological weapons.

Full text

PDF
42

Images in this article

45Fig. 1
on p.45
46Fig. 2
on p.46
48Fig. 3
on p.48
49Fig. 4
on p.49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramova F. A., Grinberg L. M., Yampolskaya O. V., Walker D. H. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2291–2294. doi: 10.1073/pnas.90.6.2291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Breman J. G., Henderson D. A. Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism. N Engl J Med. 1998 Aug 20;339(8):556–559. doi: 10.1056/NEJM199808203390811. [DOI] [PubMed] [Google Scholar]
  3. Christopher G. W., Cieslak T. J., Pavlin J. A., Eitzen E. M., Jr Biological warfare. A historical perspective. JAMA. 1997 Aug 6;278(5):412–417. [PubMed] [Google Scholar]
  4. Cole L. A. The specter of biological weapons. Sci Am. 1996 Dec;275(6):60–65. doi: 10.1038/scientificamerican1296-60. [DOI] [PubMed] [Google Scholar]
  5. Evans M. E., Gregory D. W., Schaffner W., McGee Z. A. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985 Jul;64(4):251–269. [PubMed] [Google Scholar]
  6. Finkel E. Australia. Engineered mouse virus spurs bioweapon fears. Science. 2001 Jan 26;291(5504):585–585. doi: 10.1126/science.291.5504.585. [DOI] [PubMed] [Google Scholar]
  7. Franz D. R., Jahrling P. B., Friedlander A. M., McClain D. J., Hoover D. L., Bryne W. R., Pavlin J. A., Christopher G. W., Eitzen E. M., Jr Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997 Aug 6;278(5):399–411. doi: 10.1001/jama.278.5.399. [DOI] [PubMed] [Google Scholar]
  8. Holloway H. C., Norwood A. E., Fullerton C. S., Engel C. C., Jr, Ursano R. J. The threat of biological weapons. Prophylaxis and mitigation of psychological and social consequences. JAMA. 1997 Aug 6;278(5):425–427. [PubMed] [Google Scholar]
  9. Housewright R. D., Glassman H. N. Concluding remarks of the Second International Conference on Aerobiology (Airborne Infection). Bacteriol Rev. 1966 Sep;30(3):696–698. doi: 10.1128/br.30.3.696-698.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Inglesby T. V., Grossman R., O'Toole T. A plague on your city: observations from TOPOFF. Clin Infect Dis. 2001 Jan 29;32(3):436–445. doi: 10.1086/318513. [DOI] [PubMed] [Google Scholar]
  11. Jezek Z., Gromyko A. I., Szczeniowski M. V. Human monkeypox. J Hyg Epidemiol Microbiol Immunol. 1983;27(1):13–28. [PubMed] [Google Scholar]
  12. Kaufmann A. F., Meltzer M. I., Schmid G. P. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis. 1997 Apr-Jun;3(2):83–94. doi: 10.3201/eid0302.970201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Khan A. S., Morse S., Lillibridge S. Public-health preparedness for biological terrorism in the USA. Lancet. 2000 Sep 30;356(9236):1179–1182. doi: 10.1016/S0140-6736(00)02769-0. [DOI] [PubMed] [Google Scholar]
  14. Lederberg J. Infectious disease and biological weapons. Prophylaxis and mitigation. JAMA. 1997 Aug 6;278(5):435–436. [PubMed] [Google Scholar]
  15. Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Shelokov A., Yampolskaya O. The Sverdlovsk anthrax outbreak of 1979. Science. 1994 Nov 18;266(5188):1202–1208. doi: 10.1126/science.7973702. [DOI] [PubMed] [Google Scholar]
  16. PLOTKIN S. A., BRACHMAN P. S., UTELL M., BUMFORD F. H., ATCHISON M. M. An epidemic of inhalation anthrax, the first in the twentieth century. I. Clinical features. Am J Med. 1960 Dec;29:992–1001. doi: 10.1016/0002-9343(60)90079-6. [DOI] [PubMed] [Google Scholar]
  17. Pile J. C., Malone J. D., Eitzen E. M., Friedlander A. M. Anthrax as a potential biological warfare agent. Arch Intern Med. 1998 Mar 9;158(5):429–434. doi: 10.1001/archinte.158.5.429. [DOI] [PubMed] [Google Scholar]
  18. Redmond C., Pearce M. J., Manchee R. J., Berdal B. P. Deadly relic of the Great War. Nature. 1998 Jun 25;393(6687):747–748. doi: 10.1038/31612. [DOI] [PubMed] [Google Scholar]
  19. Simon J. D. Biological terrorism. Preparing to meet the threat. JAMA. 1997 Aug 6;278(5):428–430. doi: 10.1001/jama.278.5.428. [DOI] [PubMed] [Google Scholar]
  20. Strauss E. New clue to how anthrax kills. Science. 1998 May 1;280(5364):676–676. doi: 10.1126/science.280.5364.676. [DOI] [PubMed] [Google Scholar]
  21. Wade N. Death at Sverdlovsk: a critical diagnosis. Science. 1980 Sep 26;209(4464):1501–1502. doi: 10.1126/science.7433972. [DOI] [PubMed] [Google Scholar]
  22. Walker D. H., Yampolska O., Grinberg L. M. Death at Sverdlovsk: what have we learned? Am J Pathol. 1994 Jun;144(6):1135–1141. [PMC free article] [PubMed] [Google Scholar]
  23. Zilinskas R. A. Iraq's biological weapons. The past as future? JAMA. 1997 Aug 6;278(5):418–424. [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES